Chronic Myelogenous Leukemia, Ph1-Positive
1 clinical trials · Condition
◉ Watch Chronic Myelogenous Leukemia, Ph1-Positive
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS (NCT02923986) | Bio-Path Holdings, Inc. | 2017-09-01 |
Track Chronic Myelogenous Leukemia, Ph1-Positive automatically
Every clearance here is in the API, with alerts when new ones post.